| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.21 | 7e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 0.0003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 0.0007 |